pre-IPO PHARMA

COMPANY OVERVIEW

Nocion Therapeutics, Inc. is a pre-clinical stage biotech developing novel small molecules that selectively silence nociceptors involved in aberrant cough, pain and itch responses.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Neurological Disorders
  • Pain

  • WEBSITE

    https://labcentral.org/resident-companies/nocion-therapeutics


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    bioinnovation-capital canaan-partners f-prime-capital-partners partners-innovation-fund


    PRESS RELEASES


    Aug 31, 2021

    Nocion Therapeutics Announces Dosing Underway in Participants with Chronic Cough


    Sep 1, 2020

    Nocion Therapeutics Advances to Clinical Stage and Expands Leadership


    Jan 6, 2020

    Pulmatrix Announces Research Collaboration with Nocion Therapeutics to Explore Inhaled Drug Delivery Technologies


    For More Press Releases


    Google Analytics Alternative